Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
E3 ubiquitin-protein ligase SH3RF1 (SH3 domain containing ring finger 1, also known as POSH) is a multidomain protein containing an N-terminal RING-finger, four SH3 domains, and a Rac-binding region[1][3][4][5][7]. SH3RF1 functions as a RING-type E3 ubiquitin ligase, mediating ubiquitination of target proteins, which regulates their degradation or trafficking—particularly in processes like protein sorting at the trans-Golgi network and potassium channel endocytosis[1][3]. It acts as a scaffold protein facilitating the assembly and activation of the c-Jun N-terminal kinase (JNK) signaling complex, thus playing a role in signal transduction cascades involving Rho GTPases (notably Rac1/2), MAPK kinases, and other molecules[1]. SH3RF1 is implicated in the regulation of apoptosis, acting as a pro-apoptotic factor that induces JNK activation and cell death; it is involved in T-cell differentiation, specifically promoting T-helper 1 (Th1) lineage commitment[2]. Additionally, SH3RF1 plays a crucial role in neuronal migration during brain development by supporting cortical neuron migration and F-actin assembly[1][6]. The gene has been associated with several disease processes, including hereditary breast-ovarian cancer syndrome, lissencephaly, and possibly other cancers and neurodevelopmental disorders[1]. In the context of viral infection, SH3RF1 is essential for targeting HIV-1 Gag protein to the plasma membrane through its E3 ligase activity[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E3 ubiquitin-protein ligase SH3RF1 (SH3RF1).